Ansa Biotechnologies is redefining DNA synthesis with a bold commitment to quality, customer satisfaction, and success. Ansa’s proprietary enzymatic synthesis platform can rapidly and accurately produce even the highly complex DNA elements that stymie legacy approaches. Products are delivered as sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragments and are backed by the industry's only on-time shipping guarantee. Ansa is empowering a global community of scientists to accelerate breakthroughs in healthcare, life sciences, and other industries powered by synthetic DNA. Discover more at ansabio.com or follow the company on X, Bluesky, and LinkedIn.